Vizuro and DCB Partner to Transform Drug Discovery with Causal Generative AI
January 3, 2025
Vizuro LLC, a leading innovator in multimodal causal AI technology, and the Development Center for Biotechnology (DCB) announced the signing of a Memorandum of Understanding